I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Long-term economic evaluation of the recombinant Mycobacter..:
Sha Diao
;
Zheng Liu
;
Dan Liu
...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1161526/full. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1161526
RT Journal T1
Long-term economic evaluation of the recombinant Mycobacterium tuberculosis fusion protein (EC) test for the diagnosis of Mycobacterium tuberculosis infection
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:6a68aec3e51848e5abeecc006df393f0&Exemplar=1&LAN=DE A1 Sha Diao A1 Zheng Liu A1 Dan Liu A1 Xiao Cheng A1 Linan Zeng A1 Xue-Feng Jiao A1 Zhe Chen A1 Xiaofeng Ni A1 Siyi He A1 Bin Wu A1 Deying Kang A1 Chaomin Wan A1 Rongsheng Zhao A1 Huiqing Wang A1 Lingli Zhang PB Frontiers Media S.A. YR 2023 K1 recombinant Mycobacterium tuberculosis fusion protein (EC) K1 purified protein derivative of tuberculin (TB-PPD) K1 Mycobacterium tuberculosis infection K1 decision tree-markov model K1 cost-utility K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2023.1161526/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1161526 DO https://doi.org/10.3389/fphar.2023.1161526 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)